Patents by Inventor Christopher J. Stanley

Christopher J. Stanley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8658374
    Abstract: Aggregating proteins such as IgG, are bound selectively in the presence of the non-aggregated protein using a polyionic binding agent such as dextran sulphate or pentosan (anionic), or polyamine compounds such as pDADMAC (cationic) under selective binding conditions including the use of n-lauroylsarcosine at mildly alkaline pH, and may then be assayed.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: February 25, 2014
    Assignee: Microsens Biphage Limited
    Inventors: Amin Reza Lane, Christopher J. Stanley, Stuart Mark Wilson
  • Patent number: 8460885
    Abstract: A process for the selective binding of an aggregating abnormal form of a protein in the presence of the nonaggregating normal form of the protein, including contacting under selective binding conditions a material containing both the abnormal and normal forms with a binding agent which is a polyionic material having a binding avidity for the aggregating form of the protein as present in the sample.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: June 11, 2013
    Assignee: Microsens Biophage Limited
    Inventors: Amin Reza Lane, Christopher J. Stanley, Stuart Mark Wilson
  • Publication number: 20120009595
    Abstract: Aggregating proteins such as IgG, are bound selectively in the presence of the non-aggregated protein using a polyionic binding agent such as dextran sulphate or pentosan (anionic), or polyamine compounds such as pDADMAC (cationic) under selective binding conditions including the use of n-lauroylsarcosine at mildly alkaline pH, and may then be assayed.
    Type: Application
    Filed: July 14, 2011
    Publication date: January 12, 2012
    Applicant: MICROSENS BIOPHAGE LIMITED
    Inventors: Amin Reza LANE, Christopher J. Stanley, Stuart Mark Wilson
  • Publication number: 20100184054
    Abstract: A process for the selective binding of an aggregating abnormal form of a protein in the presence of the nonaggregating normal form of the protein, including contacting under selective binding conditions a material containing both the abnormal and normal forms with a binding agent which is a polyionic material having a binding avidity for the aggregating form of the protein as present in the sample.
    Type: Application
    Filed: December 22, 2009
    Publication date: July 22, 2010
    Applicant: MICROSENS BIOPHAGE LIMITED
    Inventors: Amin R. Lane, Christopher J. Stanley, Stuart M. Wilson
  • Patent number: 7659076
    Abstract: Infective aggregating forms of proteins such as PrP, amyloid, and tau are bound selectively in the presence of the normal form protein using a polyionic binding agent such as dextran sulphate or pentosan (anionic), or polyamine compounds such as pDADMAC (cationic) under selective binding conditions including the use of n-lauroylsarcosine at mildly alkaline pH, and may then be assayed.
    Type: Grant
    Filed: February 28, 2003
    Date of Patent: February 9, 2010
    Assignee: Microsens Biophage Limited
    Inventors: Amin R. Lane, Christopher J. Stanley, Stuart M. Wilson
  • Patent number: 7279311
    Abstract: A nucleic acid primer is bound to a soluble carrier macromolecule, a multitude of primer molecules thus being carried by each carrier macromolecule, and hybridisation of the primer to a template followed by extension of the primer to replicate the template in complementary form is carried out as part of a PCR procedure or other amplification, or to form an extended primer of greater hybridisation affinity. A second primer used in the amplification may also be bound to a carrier macromolecule.
    Type: Grant
    Filed: January 17, 2001
    Date of Patent: October 9, 2007
    Assignee: Oakville Trading Hong Kong Limited
    Inventor: Christopher J. Stanley
  • Patent number: 6625479
    Abstract: An implantable sensor for use in the detection or quantitative measurement of an analyte in subcutaneous fluid, the sensor being biodegradable or hydrolysable in vivo. The sensor incorporates an assay for the analyte, the readout of which is a detectable or measurable optical signal which can, when the sensor is in operation in a subcutaneous location, be interrogated transcutaneously by external optical means.
    Type: Grant
    Filed: October 1, 2001
    Date of Patent: September 23, 2003
    Assignee: Torsana Diabetes Diagnostics A/S
    Inventors: Anders Weber, Christopher J. Stanley
  • Patent number: 6613527
    Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promoter compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.
    Type: Grant
    Filed: April 15, 2002
    Date of Patent: September 2, 2003
    Assignee: Affymetrix, Inc.
    Inventor: Christopher J. Stanley
  • Patent number: 6395489
    Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promoter compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.
    Type: Grant
    Filed: May 10, 2000
    Date of Patent: May 28, 2002
    Assignee: Affymetrix, Inc.
    Inventor: Christopher J. Stanley
  • Patent number: 6365400
    Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promoter compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.
    Type: Grant
    Filed: June 20, 2000
    Date of Patent: April 2, 2002
    Assignee: Affymetrix, Inc.
    Inventor: Christopher J. Stanley
  • Publication number: 20010004527
    Abstract: A nucleic acid primer is bound to a soluble carrier macromolecule, a multitude of primer molecules thus being carried by each carrier macromolecule, and hybridisation of the primer to a template followed by extension of the primer to replicate the template in complementary form is carried out as part of a PCR procedure or other amplification, or to form an extended primer of greater hybridisation affinity. A second primer used in the amplification may also be bound to a carrier macromolecule.
    Type: Application
    Filed: January 17, 2001
    Publication date: June 21, 2001
    Applicant: AMDEX A/S
    Inventor: Christopher J. Stanley
  • Patent number: 6207385
    Abstract: A nucleic acid primer is bound to a soluble carrier macromolecule, a multitude of primer molecules thus being carried by each carrier macromolecule, and hybridisation of the primer to a template followed by extension of the primer to replicate the template in complementary form is carried out as part of a PCR procedure or other amplification, or to form an extended primer of greater hybridization affinity. A second primer used in the amplification may also be bound to a carrier macromolecule.
    Type: Grant
    Filed: May 18, 1999
    Date of Patent: March 27, 2001
    Assignee: Amdex A/S
    Inventor: Christopher J. Stanley
  • Patent number: 6197508
    Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promoter compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction. A process is described for annealing complementary strands of nucleic acid by application of an electrical voltage.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: March 6, 2001
    Assignee: Affymetrix, Inc.
    Inventor: Christopher J. Stanley
  • Patent number: 5824477
    Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promoter compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.
    Type: Grant
    Filed: April 1, 1996
    Date of Patent: October 20, 1998
    Assignee: Scientific Generics Limited
    Inventor: Christopher J. Stanley
  • Patent number: 5814450
    Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process employs a promoter which is an inorganic multivalent cation such as a magnesium ion to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.
    Type: Grant
    Filed: December 5, 1996
    Date of Patent: September 29, 1998
    Assignee: Scientific Generics Ltd.
    Inventors: Christopher J. Stanley, Patricia L. Archer
  • Patent number: 5607832
    Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process employs a promoter which is an inorganic multivalent cation such as magnesium ions to speed denaturation. The process may be used in the detection of nucleic acid by hybridrising with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.
    Type: Grant
    Filed: November 18, 1994
    Date of Patent: March 4, 1997
    Assignee: Scientific Generics Limited
    Inventors: Christopher J. Stanley, Patricia L. Archer
  • Patent number: 5527670
    Abstract: A process is described for denaturing native double-stranded nucleic acid material into its individual strands in an electrochemical cell. The process disclosed is an electrical treatment of the nucleic acid with a voltage applied to the nucleic acid material by an electrode. The process may also employ a promotor compound such as methyl viologen to speed denaturation. The process may be used in the detection of nucleic acid by hybridizing with a labelled probe or in the amplification of DNA by a polymerase chain reaction or ligase chain reaction.
    Type: Grant
    Filed: August 9, 1994
    Date of Patent: June 18, 1996
    Assignee: Scientific Generics Limited
    Inventor: Christopher J. Stanley
  • Patent number: 5116576
    Abstract: A device for carrying out an analytical determination which comprises an assay cassette and a transport body which is adapted for location in the assay cassette, the assay cassette having a plurality of discrete reagent chambers which are separated from one another by a separation arrangement which, in use, is ruptured or opened by the transport body. An assay cassette is also described which includes a signal detection chamber that is separated from the final reagent chamber by a separation arrangement which, in use, is ruptured or opened by the transport body.
    Type: Grant
    Filed: August 2, 1990
    Date of Patent: May 26, 1992
    Assignee: Scientific Generics Limited
    Inventor: Christopher J. Stanley